Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment

被引:41
作者
Caers, Jo [1 ]
Van Valckenborgh, Els [1 ]
Menu, Eline [1 ]
Van Camp, Benjamin [1 ]
Vanderkerken, Karin [1 ]
机构
[1] Vrije Univ Brussel, Lab Hematol & Immunol, B-1090 Brussels, Belgium
关键词
cancerogenesis; biology; multiple myeloma;
D O I
10.1684/bdc.2008.0600
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Cancerogenesis is believed to be a multistep process composed of different alterations that drive the transformation of normal human cells into highly malignant derivatives. These changes include self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, the evasion of programmed cell death, a limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. Some evidence suggests that these cancer cells are derived from immature, proliferative precursors that feed the cancer cell compartment. Both, precursors and cancer cells, intensively interact with their surroundings, commonly described as their micro-environment, The processes above are also important in the biology of multiple myeloma, a malignant bone marrow disorder consisting of monoclonal plasma cells accumulation. In the current review we describe the biology of this disease, stressing the origin of myeloma cells, their acquired genetic changes and interactions with their hone marrow microenvironment.
引用
收藏
页码:301 / 313
页数:13
相关论文
共 80 条
[1]
Chemokines in multiple myeloma [J].
Aggarwal, Rohit ;
Ghobrial, Irene A. ;
Roodman, G. David .
EXPERIMENTAL HEMATOLOGY, 2006, 34 (10) :1289-1295
[2]
Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines [J].
Alexandrakis, MG ;
Passam, FH ;
Sfiridaki, A ;
Pappa, CA ;
Moschandrea, JA ;
Kandidaki, E ;
Tsirakis, G ;
Kyriakou, DS .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (01) :52-57
[3]
Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity [J].
Asosingh, K ;
De Raeve, H ;
Menu, E ;
Van Riet, I ;
Van Marck, E ;
Van Camp, B ;
Vanderkerken, K .
BLOOD, 2004, 103 (08) :3131-3137
[4]
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma [J].
Asosingh, K ;
Menu, E ;
Van Valckenborgh, E ;
Vande Broek, I ;
Van Riet, I ;
Van Camp, B ;
Vanderkerken, K .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) :583-591
[5]
BAKKUS MHC, 1992, BLOOD, V80, P2326
[6]
EVIDENCE THAT THE CLONOGENIC CELL IN MULTIPLE-MYELOMA ORIGINATES FROM A PRE-SWITCHED BUT SOMATICALLY MUTATED B-CELL [J].
BAKKUS, MHC ;
VANRIET, I ;
VANCAMP, B ;
THIELEMANS, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (01) :68-74
[7]
Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells [J].
Barille, S ;
Akhoundi, C ;
Collette, M ;
Mellerin, MP ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 1997, 90 (04) :1649-1655
[8]
Molecular pathogenesis and a consequent classification of multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6333-6338
[9]
Tumors and inflammatory infiltrates: Friends or foes? [J].
Brigati, C ;
Noonan, DM ;
Albini, A ;
Benelli, R .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (03) :247-258
[10]
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1,-2 and-3 [J].
Broek, IV ;
Asosingh, K ;
Vanderkerken, K ;
Straetmans, N ;
Van Camp, B ;
Van Riet, I .
BRITISH JOURNAL OF CANCER, 2003, 88 (06) :855-862